Core Laboratories N.V.
General ticker "CLB" information:
- Sector: Energy
- Industry: Oil & Gas Equipment & Services
- Capitalization: $705.9M (TTM average)
Core Laboratories N.V. does not follow the US Stock Market performance with the rate: -28.8%.
Estimated limits based on current volatility of 1.9%: low 9.71$, high 10.08$
Factors to consider:
- Earnings expected soon, date: 2026-10-28 amc
- Company pays dividends (quarterly): last record date 2026-08-10, amount 0.01$ (Y0.40%)
- Total employees count: 3300 (-5.7%) as of 2025
- US accounted for 34.0% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Economic downturns and volatility, Pandemic risks, Cost cutting measures, Ukrainian crisis, Cybersecurity threats
- Current price 15.2% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.64$, 20.42$]
- 2025-12-31 to 2026-12-31 estimated range: [11.79$, 20.54$]
Financial Metrics affecting the CLB estimates:
- Positive: with PPE of 19.3 at the end of fiscal year the price was neutral
- Positive: 7.80 < Operating profit margin, % of 11.18
- Positive: 6.77 < Operating cash flow per share per price, % of 7.08
- Positive: 42.26 < Shareholder equity ratio, % of 42.68 <= 49.86
- Positive: Interest expense per share per price, % of 1.55 <= 2.54
- Positive: Inventory ratio change, % of -2.88 <= -1.30
- Positive: -1.23 < Investing cash flow per share per price, % of -0.80
- Negative: Industry operating profit margin (median), % of 8.58 <= 14.78
- Positive: 3.58 < Industry earnings per price (median), % of 4.21
- Positive: Industry inventory ratio change (median), % of 0.83 <= 1.15
Short-term CLB quotes
Long-term CLB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $490.46MM | $509.79MM | $523.85MM |
| Operating Expenses | $448.93MM | $455.15MM | $465.29MM |
| Operating Income | $41.52MM | $54.64MM | $58.56MM |
| Non-Operating Income | $-11.57MM | $-13.43MM | $-12.37MM |
| Interest Expense | $11.57MM | $13.43MM | $12.37MM |
| Income(Loss) | $29.95MM | $41.21MM | $46.19MM |
| Taxes | $10.30MM | $4.18MM | $14.03MM |
| Net Income(Loss)* | $19.45MM | $36.67MM | $31.40MM |
| Stockholders Equity | $184.26MM | $224.81MM | $251.99MM |
| Inventory | $60.45MM | $71.70MM | $59.40MM |
| Assets | $578.35MM | $586.39MM | $590.41MM |
| Operating Cash Flow | $24.96MM | $24.79MM | $56.39MM |
| Capital expenditure | $10.22MM | $10.58MM | $13.03MM |
| Investing Cash Flow | $-3.86MM | $-6.65MM | $-6.39MM |
| Financing Cash Flow | $-23.38MM | $-18.45MM | $-45.96MM |
| Earnings Per Share** | $0.42 | $0.79 | $0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.